Vigilant Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$16.7M Sell
48,794
-1,397
-3% -$423K 1.25% 36
2023
Q1
$12.8M Sell
50,191
-413
-0.8% -$102K 1.04% 38
2022
Q4
$13.4M Buy
50,604
+738
+1% +$180K 1.15% 37
2022
Q3
$9.35M Buy
49,866
+1,549
+3% +$333K 0.88% 42
2022
Q2
$9.7M Buy
48,317
+3,164
+7% +$742K 0.84% 43
2022
Q1
$13.6M Buy
45,153
+1,311
+3% +$383K 1.04% 40
2021
Q4
$15.8M Sell
43,842
-330
-0.7% -$114K 1.1% 40
2021
Q3
$14.6M Sell
44,172
-1,521
-3% -$511K 1.17% 43
2021
Q2
$14M Sell
45,693
-1,383
-3% -$388K 1.13% 42
2021
Q1
$11.6M Buy
47,076
+678
+1% +$171K 1.03% 41
2020
Q4
$12.7M Sell
46,398
-618
-1% -$153K 1.21% 41
2020
Q3
$11.1M Buy
47,016
+51
+0.1% +$11.5K 1.22% 40
2020
Q2
$8.92M Sell
46,965
-444
-0.9% -$79.6K 1.08% 42
2020
Q1
$7.83M Buy
+47,409
New +$8.68M 1.14% 42
2016
Q3
Sell
-90
Closed -$7K 335
2016
Q2
$7K Hold
90
﹤0.01% 300
2016
Q1
$6K Hold
90
﹤0.01% 223
2015
Q4
$5K Buy
+90
New +$5.05K ﹤0.01% 250

Other funds holding ISRG

Vigilant Capital Management's ISRG Position: Q2 2023 in Review

Vigilant Capital Management reduced its Intuitive Surgical (ISRG) stake by 2.8% in Q2 2023, selling an estimated $423K and leaving 48,794 shares worth $16.7M. The position accounts for 1.25% of the portfolio, ranked #36.

Vigilant Capital Management first reported a position in ISRG in Q4 2015 and has held it in 17 quarters since. 1,556 funds tracked by Wall St. Rank hold ISRG as of Q2 2023.

  • Vigilant Capital Management held 48,794 shares of Intuitive Surgical worth $16.7M as of Q2 2023.
  • Vigilant Capital Management sold 1,397 Intuitive Surgical shares in Q2 2023, an estimated $423K.
  • Intuitive Surgical made up 1.25% of Vigilant Capital Management's portfolio in Q2 2023, its #36 holding.
  • Vigilant Capital Management first reported a position in Intuitive Surgical in Q4 2015 and has held it in 17 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.